NUVL - Nuvalent Inc Class A (Healthcare: Biotechnology) Projected Earnings Date: 2026-01-28    (Delayed quote data   2026-02-10)
Last
 102.08		 Change
 ⇓ -0.91   (-0.88%)		 Volume
  407,399
Open
 103.79		 High
 105.68		 Low
 101.82
8EMA (Daily)
 103.38		 40EMA (Daily)
 103.48		 50EMA (Daily)
 102.84		 STO (Daily)
 22.218		 MACD Hist (Daily)
 -0.406
8EMA (Weekly)
 103.267		 40EMA (Weekly)
 93.03		 50EMA (Weekly)
 90.88		 STO (Weekly)
 62.112		 MACD Hist (Weekly)
 -1.360
Company Profile
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2026 OptionChance.com